Chapter thirteen
The Patch
Three days after the initial crisis meeting, Daniel had barely slept. He'd spent forty-eight hours in the lab running simulations that all ended in the same grim conclusion: any reversal protocol would be as unpredictable as the original accident. When the second meeting was called — this time by Marcus, with a terse email marked "Urgent: Monetization Strategy" — Daniel knew the corporation had moved from damage control to exploitation. He arrived at the smaller chamber thirty minutes early, a windowless oval room that felt like a bunker, with climate control so precise it might have been managed by gene-edited bacteria. He chose the seat furthest from the projection screen, arranging his useless notes before him. Helen slipped in moments later, her neutral smile attempting comfort but settling for solidarity.
The room filled with the practiced choreography of power: bags unzipping, pens clicking in quick, nervous clusters, the faint rattle of dry coffee pods in a tray. Once, Daniel might have found a perverse pleasure in this ballet, the symphonic hum of minds working at cross-purposes. Today, the rhythms only sickened him.
The CFO opened with a ritual cough. “Let’s get to it,” he said, voice reverberating as if from a hidden megaphone.
The Marketing Director took immediate command, plugging her phone into the console. The first slide appeared: a heat map of user “activations,” the world glowing with unnatural luster. The numbers — Daniel couldn’t help it — were staggering. Three hundred million affected in the first hour, a billion by the morning of Day Three. He imagined the invisible virus lancing through fiber, airwaves, even the idle dreams of the planet’s sleeping billions.
“Adoption rate exceeded all forecasts,” she purred, laser pointer skittering across continents. “We are, in every sense, the dominant paradigm. But conversion is only the first step. The revenue model is where the real innovation occurs.”
She let the pause hang, inviting awe.
“Here’s how we play it: The default switch is technically reversible, but only at intervals. We frame the patch as an experience, a journey of self-exploration, with premium tiers for instant flexibility. That opens us up to a recurring revenue model — annual, monthly, even daily resets. Think of the up-sell potential: couples’ packages, corporate plans, custom orientation tuning for celebrities, and so on.”
The CFO’s face, normally as animated as a limestone monument, broke into a grin. “Brilliant,” he said, turning to the Legal Officer, whose lips compressed into a thin, bloodless line.
“We’re already seeing mass action litigation,” she said, voice dry as paper. “The precedent is not in our favor. There’s also a real risk of state intervention, especially if the EU makes it a sovereignty issue.”
Marcus, who had been reading from his tablet, finally spoke. “There’s no patch yet,” he said quietly. “We can’t sell a thing we don’t have.”
The Director waved this off. “Beta is sufficient for rollout. The point is to position us as the indispensable solution, so when the competitors arrive, we control the market language. It’s not about fixing what’s broken, Marcus. It’s about defining what’s normal.”
Daniel listened as if underwater. Sweat bloomed along the hairline above his ears. The slide deck advanced: projections, trending lines, quotes from social media influencers, even a meme or two to puncture the tension. The memes disturbed him most; they were like viral proteins — funny, infectious, indifferent to their own consequences.
Helen caught his eye. Her gaze lingered just a second too long, as if to steady him by force of will alone.
The CFO turned to Daniel, eyebrows raised. “From a scientific perspective, how soon can we deliver this as a product?”
“Not immediately,” he said. “We’re still quantifying the off-target effects. Some subjects are reporting…unintended side effects.”
“Such as?”
The list was endless: depersonalization, obsessive guilt, vivid dreams of impossible families, sudden attachments to inanimate objects. Once, Daniel had found the stories funny — one man in Des Moines had fallen violently in love with the concept of the quadratic equation — but now, every report struck him as an accusation.
“Emotional instability,” he managed. “Personality drift. A kind of existential vertigo. Some patients are resisting the patch even after requesting it.”
The Director leaned in, an apex predator scenting vulnerability. “Meaning?”
“Meaning,” said Daniel, “they’re conflicted about whether to revert. The data suggest a large number are…ambivalent.”
There was a moment of perfect stillness, as if the oxygen had been siphoned from the room.
“Then the patch is not a cure,” the CFO pronounced. “It’s a lifestyle product.”
The Marketing Director smiled, dazzling. “Precisely.”
The rest of the meeting was a chorus of consensus, punctuated by the Chief Legal’s constant refrain of risk mitigation and Marcus’s half-hearted attempts at ethical caution. Daniel receded into himself and he listened now, impassive, as the others performed the motions of governance, their language less a dialect than a system of encryption — intended, above all, to keep the world at bay.
It was the CFO, leaning back in his chair and cradling his coffee cup like a relic, who delivered the line that would, retrospectively, serve as the last straw: “Market penetration rates are promising, but to reach the next plateau we need to maximize…”
He never finished. Daniel’s hand — the left, with its blue-black tattoo of regret — slammed onto the table so abruptly that even Helen jerked as though an electric current had been passed beneath the quartz. The sound was not loud, not in an absolute sense, but in the acoustics of the room, it was a kind of verdict.
Every face turned to him. Even the Legal Officer’s mask slipped, for a split second, into a blankness so total that it seemed she had never possessed a face at all.
Daniel’s voice, when it came, was impossibly calm. “Could you all stop for a second,” he said, not as a plea but a command. “Stop talking about ‘penetration rates’ as if you’re discussing market shares or consumer uptake. We did this. We. Not the market. Not a rogue algorithm. Not even the ghost of Steve Jobs. We made this world, and now we’re scrambling to monetize the pain.”
A hush followed. He stood, his chair scraping back with a sound like bones dragged over glass, and began to pace the perimeter of the table, hands trembling only slightly.
“Let’s do this properly,” he said. “Let’s be honest for once.”
He turned to the Marketing Director first, who had already begun to collect herself, jaw squared for the incoming assault. “You want to pitch the reversal patch as a lifestyle accessory. You want to sell sexual orientation as a personalizable, reversible, endlessly upgradable feature, like a phone skin or a set of ringtones. You’ll say it’s for the sake of self-exploration, but you know as well as I do that you’re selling confusion and misery by subscription. You’ll get the first week free, and after that, it’s pay-to-play. The entire planet held hostage to a thirty-day trial. Is that about right?”
She opened her mouth, but the words failed her. For the first time, Daniel realized, she looked almost human.
He moved on to the CFO, who gripped his mug with both hands, knuckles blanched. “You’re not a villain, are you? No. You’re a rational actor. You see everything as loss or gain, you count the blood cells and put a value on each. But what do you call the cost of a ruined childhood, a suicide, a family split in two? Is there a formula for that? Does the spreadsheet handle negative infinity?”
The CFO’s eyes narrowed. “You don’t understand how —”
“Oh, I understand perfectly,” Daniel shot back. “You’ll put it in the footnotes and declare victory.”
The Chief Legal Officer began to speak, but Daniel cut her off with a raised hand. “And you. You’ve already written the brief. The patch isn’t a reversal, it’s an enhancement. The harm is not a crime but an opportunity. You’ll say that nobody was truly forced, that everything was opt-in after the initial…oversight. You’ll claim the victims were complicit. You always do.”
The words hung in the air, a thicket of accusation.
He let his gaze drift to Marcus, whose hands now fidgeted so violently it seemed they might take flight. “And you, Marcus. You’re the ethical voice in the room, the guy who says ‘public trust’ with a straight face. But you knew. You saw the memo before I did, didn’t you? You were the first to run the numbers. Why didn’t you say something?”
Marcus’s reply was soft, almost a whisper. “I thought I could fix it. That if I kept quiet, we could mitigate…”
“Mitigate,” Daniel echoed, the word sour in his mouth. “You’re all so afraid of the worst-case, you can’t see what’s in front of you, Marcus. Some people are losing themselves, even dying, and you want to manage the optics.”
“I’m done,” Daniel said. “I won’t participate in this anymore. I won’t design your next fix, or your patch, or your damn product launch. If you try to force me, I’ll burn this place to the ground, and I’ll publish everything — all the notes, all the code, all the messages you thought you deleted. I’ll walk straight to your competitors and show them the keys to your kingdom.”
He inhaled, deeply, feeling the air ignite his lungs. The trembling had vanished, replaced by an almost joyous clarity.
“I’m going to make a patch,” he said. “A real one. A patch that actually gives people a choice. No subscription, no up-sell, no lock-in. They’ll get the antidote for free. I don’t care if I get sued, or killed, or blackballed from every conference on the continent. I’m done being your puppet.”
The silence that followed was absolute, as if even the air had stopped believing in the meeting’s reality.
Helen was the first to recover. She rose, walked around the table, and put a hand on his shoulder, firm and warm. “I’ll help,” she said. “Whatever you need.”
The others sat, stunned, locked in a tableau of defeat. The CFO tried to reassert himself — “You’ll be liable for —” — but the words dissolved in the face of Daniel’s refusal to even look back.
The Marketing Director gave a strangled laugh, then began to gather her things, muttering about “resilience” and “pivoting to a new paradigm,” but even she could not disguise the fear in her eyes.
As Daniel left the room, Helen at his side, the table of executives looked less like architects of the future and more like children at the scene of an accident, desperately rehearsing the story they would tell their parents.
In the corridor, Daniel felt a sensation he could barely name: relief, maybe, or hope, or the faint aftertaste of revenge. He flexed his left hand, watching the ink stain pulse and fade with each heartbeat, and thought, for the first time in weeks, that he might live to see the world repaired.
The elevator doors opened on the tenth floor, where even the air was so clean it seemed engineered. Daniel ignored the residual hush of conversation behind glass, the averted gazes of project managers orbiting in pairs, the security guard whose slow rise from his stool signaled a memo he hadn’t yet received. He walked straight to the lab entrance, pressed his left palm against the scanner. The door’s click was delicate, a dental sound, intimate and final. He paused at the threshold, heart pounding in a way that was almost pleasurable, and allowed himself a single, steadying breath.
He shrugged off his jacket, rolling the sleeves of his dress shirt to the elbow. The chill bit at his arms, but the sensation grounded him, reminded him of the first time he’d snuck into a genetics lab at Charles University, Prague, running PCRs under the nose of a tenured tyrant. The nostalgia was instantly overlaid by shame. First, he re-entered the central server. The next sequence of gestures — logging in, typing his password, ignoring the “Welcome Back, Daniel” — was pure muscle memory.
A gentle whine spun up the drives. The main screens flickered, then filled with a tangle of live readouts: gene expression, viral load, patch transmission data, and — like a ghost in the background — the original cascade that had broken the world. The code was there, untouched, a fossil record of hubris.
He stared at it for a long time. The interface was familiar, but the feeling was not: this was no longer his child or his adversary. It was a mirror, and it reflected every choice he’d ever failed to make.
Helen entered then, quietly, a cup of something hot in one hand. She placed it beside him and said nothing. She took the farthest bench, logged in to a terminal, and began assembling gene drive protocols, her face set to a quiet, absolute focus.
Daniel muttered to himself as he worked. “If A then B, but B is not stable unless C is…” He ran through the dependencies, testing and retesting, breaking apart the code like a priest parsing scripture for heresy. Each change he made was a confession; each failed compile, a penance.
He wondered, more than once, if he would break down — if the physical cost of defiance would simply shut him down, mid-line, like an organism starved for oxygen. But the opposite occurred. With every minute, his breathing steadied, the pressure in his temples faded, and the tremor in his hands — which he’d thought permanent — subsided until it was merely a tick, a leftover from another version of himself.
Day bled into night, then back to day again, the fluorescent panels overhead buzzing with the same relentless intensity at 3 AM as at noon. The lab's windowless environment made time elastic — marked only by the hum of industrial fridges cycling on with a shudder, the plastic rattle of pipettes dropping into biohazard bins, Helen's occasional keyboard clicks that sounded like distant rainfall, and the delivery of protein bars that appeared mysteriously at the door, wrapped in crinkly foil that neither of them remembered ordering. Daniel's beard grew patchy, rust-colored in some spots and nearly translucent in others; Helen's once-tight ponytail migrated lower on her head with each passing day until it hung limply at the nape of her neck. They slept in awkward two-hour bursts on the break room's vinyl couch that exhaled stale air with each shift of weight, showered in the decontamination stalls where the water always ran too hot then too cold. By the fifth day, when Daniel's fingertips had gone numb from typing and his eyes burned from screen glare, the boardroom confrontation felt like something from another life — a half-remembered dream.
He built the patch in layers, hunched over keyboards until his spine curved permanently, starting with a viral vector that would counteract the original signal — a digital vaccine reprogramming the reprogrammed, a bootloader for the soul. Versions 1 through 17 failed spectacularly, their code collapsing like houses of cards, crashing the test models with elegant, annihilating loops that left behind corrupted data like digital ash. The weekend passed unacknowledged, coffee cups multiplying like bacterial cultures along the edge of his workstation. When version 18 finally stabilized on Tuesday morning — the moment the readout flashed from angry red to a soft, pulsing green that bathed his face in its glow — Daniel, unshaven and hollow-eyed, with three days of sweat dried into his shirt collar, had to stare at it for a full sixty seconds before he allowed himself to believe it.
He hit save, then turned to Helen, who watched him over the rim of her mug. “It works,” he said. “I think it actually works.”
She smiled, not the congratulatory smile of a colleague but the faint, tired smile of someone who has waited too long for good news.
“Let’s run the live batch,” she said.
They moved together then, side by side, as if they had always been a pair. She set up the cell cultures, he pipetted the solution, and when the time came to inject the sequence, it was Helen’s hands that were perfectly steady, Daniel’s voice that counted down, “Three, two, one.” The cultures lit up, as though some tiny consciousness had blinked awake inside the petri dishes.
They watched, said nothing, waited for the protocol to either take or fail. Daniel found himself whispering to the cells, “Come on, come on,” as if they could hear.
The results appeared twenty-three minutes later, in a row of blinking blue notifications. The reversal held in 100% of samples. Daniel felt the urge to laugh, but the sound that came out was something closer to a sob.
Helen put her hand on his shoulder again. “You did it,” she said.
“No,” said Daniel, voice raw. “I just stopped making it worse.”
They’d re-engineered the original vector, stripped its replication loop, and built in a timed degradation sequence. Two intramuscular doses would deliver the corrective proteins, then self-destruct. No spread, no contagion. Controlled reversal — one body at a time.
He printed the release code, made a dozen encrypted backups, and then stared at the flash drive in his palm, its weight negligible yet somehow immense. Now he could distribute the open-source patch to every major lab, medical NGO, and tech reporter in the world. For good measure, he included the entire audit trail: every lie, every cover-up, every buried memo, all of it.
"We should offer it to Eidolon first," Daniel said, pulling his hand back. "Let them distribute it."
Helen's eyes widened. "After everything they've done?"
"The corporation that caused this becomes the source of the free reversal protocol. There's... symmetry in that."
"They'll monetize it," Helen said, her voice flat. "They'll patent it, price it, control who gets it when."
Daniel nodded, watching the screens pulse with data. "And if they do, we release it ourselves. Everywhere, all at once."
"You'd be burning every bridge."
"I already have." He rubbed his eyes. "But this way, we give them a chance to do the right thing."
"And if they don't?"
Daniel looked at the signature he'd prepared: "This is the work of Daniel Novák, formerly of Eidolon."
He imagined how when the patch is launched, the feedback would be instantaneous. The screens would light up with pings from Asia, Africa, Europe, the Americas — a planet-wide neural firework, the reversal cascading out just as the original had, only this time, by choice.
"Then the world gets to choose."